Pyrimidoacridine derivatives as potential antitumor agents
- PMID: 1445611
Pyrimidoacridine derivatives as potential antitumor agents
Abstract
A series of some N-alkylaminoalkyl derivatives of pyrimido[5,6,1-d,e]acridine-1,3,7-trione (3) was synthesized as new potential antitumor drugs, starting from the suitable 9,10-dihydro-9-oxo-4-acridinecarboxamides and using phosgene as cyclizing agent. 1-(9,10-dihydro-9-oxo-4-acridinecarbonyl)-3-alkyl-2-imidazolido nes were also obtained as side products. The final products 3 and some carboxamides were tested "in vitro" against L 1210 leukemia and "in vivo" against P388 leukemia. Of the tested compounds, one is active "in vivo", another shows significant cytotoxic activity "in vitro", but is inactive or toxic "in vivo".
Similar articles
-
Synthesis and cytotoxic and antitumor activity of esters in the 1,2-dihydroxy-1,2-dihydroacronycine series.J Med Chem. 1996 Nov 22;39(24):4762-6. doi: 10.1021/jm9602975. J Med Chem. 1996. PMID: 8941390
-
Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.Anticancer Drug Des. 1996 Jun;11(4):339-49. Anticancer Drug Des. 1996. PMID: 8679056
-
Synthesis of (dialkylamino)alkyl-disubstituted pyrimido[5,6,1- de]acridines, a novel group of anticancer agents active on a multidrug resistant cell line.J Med Chem. 1995 Aug 18;38(17):3282-6. doi: 10.1021/jm00017a013. J Med Chem. 1995. PMID: 7650682
-
DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.Curr Med Chem. 2002 Sep;9(18):1701-16. doi: 10.2174/0929867023369268. Curr Med Chem. 2002. PMID: 12171552 Review.
-
Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis.Pharmacol Rep. 2011;63(2):305-36. doi: 10.1016/s1734-1140(11)70499-6. Pharmacol Rep. 2011. PMID: 21602588 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources